Connect with us

Technology

Artificial Intelligence in Healthcare Market to Hit US$ 164.16 Billion by 2030 with 49.1% CAGR | MarketsandMarkets™

Published

1 year ago

on

DELRAY BEACH, Fla., Dec. 19, 2024 /PRNewswire/ — The global artificial intelligence in healthcare market, valued at US$10.31 billion in 2023, is forecasted to grow at a robust CAGR of 49.1%, reaching US$14.92 billion in 2024 and an impressive US$164.16 billion by 2030. The market growth is primarily driven by the increase in the chronic diseases such as heart disease, stroke, diabetes, and cancer subsequently putting significant pressure on healthcare service providers to optimize their operations. Moreover, technological advancements in machine learning algorithms, cloud computing, data analytics, and other sophisticated technologies is largely driving the market growth. Companies are updating their product portfolio to incorporate artificial intelligence into their offerings. For instance, GE Healthcare, Cognizant, and many more have upgraded their Artificial Intelligence (AI) in healthcare capabilities to enhance overall healthcare experience. However, the resistance among medical practitioners to adopt AI-based solutions, and high implementation costs are expected to restrain the market growth to a certain extent.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303

Browse in-depth TOC on “Artificial Intelligence in Healthcare Market”
455 – Tables
54 – Figures
386 – Pages

The global Artificial Intelligence (AI) in healthcare market is segmented into integrated solutions, niche/point solutions, AI technology, and services, by offering. The integrated solutions segment is accounted for the largest share in 2023. The large share of this segment is attributed to the increasing demand for seamless software-service combinations that address complex healthcare challenges like workflow optimization, predictive analytics, and personalized care. These providers enable healthcare organizations to adopt AI solutions more effectively by offering end-to-end support, from implementation to ongoing system management, which reduces operational complexity and ensures regulatory compliance. Additionally, advancements in AI-powered platforms such as clinical decision support, coupled with rising investments in healthcare IT infrastructure, fuel this trend by making integrated solutions more attractive to hospitals and clinics seeking value-based care models.

Based on tools, the AI in healthcare market is segmented into machine learning, natural language processing, generative AI, computer vision, image analysis, and other tools. In 2023, the machine learning segment accounted for the largest share of the market. The large share of this segment can be attributed to the enormous availability of data, also called big data, and the increasing adoption of ML by hospitals, research centers, and other healthcare institutions to improve patient health. ML is being implemented in healthcare to deal with large volumes of data, streamline hospital administrative processes, map and treat infectious diseases, and personalize medical treatments. These advantages are poised to increase the adoption of ML in the healthcare industry.

The Artificial Intelligence (AI) in healthcare market is divided into clinical applications and non-clinical applications, by application. In 2023, the clinical applications segment is expected to demonstrate highest growth rate during the forecast period. The high adoption of artificial intelligence (AI) in healthcare for clinical applications is driven by its ability to improve diagnostic accuracy, optimize treatment plans, and enhance patient outcomes. AI-powered tools, such as predictive analytics and imaging diagnostics, support clinicians in early disease detection and personalized care, addressing growing demands for efficiency and precision in healthcare delivery. Additionally, advancements in machine learning and natural language processing enable integration into clinical workflows, while rising investments and favourable regulatory policies further accelerate adoption.

The AI in healthcare market is studied for the five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American region dominated the market due to the high per capita healthcare expenditure, ongoing technological developments, particularly in machine learning & deep learning, the rising demand for precision medicine, and the favourable reimbursement scenario. The surging number of patients with chronic disorders and significant investments by government & private entities toward healthcare information technology further propel the growth. Moreover, the competitive scenario in North America motivates key market players to develop innovative tools, driving continuous growth in service offerings.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=54679303

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), 3M (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers and acquisitions to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

Koninklijke Philips N.V. (Netherlands) is one of the key players that offers Artificial Intelligence (AI) in healthcare solutions. Philips leverages AI in healthcare to deliver innovative solutions across diagnostic imaging, patient monitoring, and precision medicine. Its advanced AI-driven platforms, such as the Philips HealthSuite, enable the integration and analysis of vast clinical data, supporting personalized treatment plans and improved patient outcomes. AI capabilities are embedded in imaging tools enhances diagnostic accuracy and streamlines radiology workflows. The company’s solutions focus on operational efficiencies, including workflow automation and predictive analytics, empowering healthcare providers to deliver value-based care. Philips’ strong emphasis on collaboration with hospitals and technology partners further accelerates the adoption of AI in healthcare. Philips has a significant global presence, serving over 100 countries across North America, Europe, Asia-Pacific, Latin America, and Africa. Its operations are supported by a strong network of subsidiaries, including Philips Healthcare, Philips Medical Systems, and Philips Research. The company maintains strategic R&D centers in key markets and collaborates with leading medical institutions to drive innovation in health technology.

Microsoft (US) is one of the leading providers of software & tools that leverages advanced AI capabilities in healthcare to enhance patient outcomes, streamline operations, and drive innovation. Its Azure-based AI solutions support diverse applications like medical imaging, genomics, and precision medicine. Microsoft also offers healthcare-specific AI models through its Azure AI Model Catalog, designed to support hospitals and research institutions in building and deploying tailored AI solutions efficiently. Additionally, the integration of Nuance’s AI-powered clinical and diagnostic tools bolsters its capacity to support healthcare providers in decision-making and care delivery. Microsoft has a strong global presence, with key operations supported through its Azure cloud infrastructure across regions like North America, Europe, Asia-Pacific, and the Middle East. Its geographic footprint enables widespread access to advanced AI tools for healthcare providers, ensuring scalability, data security, and compliance with local regulations like GDPR in Europe and HIPAA in the U.S.

For more information, Inquire Now!

Related Reports:

Home Healthcare Market

Healthcare IT Market

Healthcare BPO Market

Artificial Intelligence in Medical Diagnostics Market

Artificial Intelligence in Genomics Market

Get access to the latest updates on Artificial Intelligence (AI) in Healthcare Companies and Artificial Intelligence (AI) in Healthcare Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

 

View original content:https://www.prnewswire.com/news-releases/artificial-intelligence-in-healthcare-market-to-hit-us-164-16-billion-by-2030-with-49-1-cagr–marketsandmarkets-302335998.html

SOURCE MarketsandMarkets

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

11 minutes ago

on

April 23, 2026

By

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029.  As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining.  The Board also declared a second quarter dividend of $0.36 per common share.  The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer.  “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion.  Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.” 

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions.  The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program.  The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services.  Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia.  Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia.  The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges.  Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia.  Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska.  Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash.  These forward-looking statements are not guarantees of future performance.  This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release.  We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Continue Reading

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

1 hour ago

on

April 23, 2026

By

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Continue Reading

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

1 hour ago

on

April 23, 2026

By

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2.   Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3.   Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4.   Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.

Continue Reading

Trending